Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02743819
Brief Title: Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

First Submitted : April 14, 2016
First Submitted that Met QC Criteria : April 15, 2016
First Posted : April 19, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 25, 2020
Last Update Posted : September 29, 2020